ENA Actimineral Resource A restores bone loss and bone quality in ovariectomized rats

被引:0
作者
Sun Hee Do
Sung-Yong Hwa
Won-Il Jeong
Ji-Won Lee
Hyun-Jung Kim
In-Seon Lee
Kyu-Shik Jeong
机构
[1] Kyungpook National University,Department of Veterinary Pathology, College of Veterinary Medicine
[2] Jinju Bio Food,The Center for Traditional Microorganism Resources
[3] Keimyung University,undefined
来源
Molecular and Cellular Biochemistry | 2007年 / 295卷
关键词
Bone turnover rate; ENA Actimineral Resource A; osteoporosis; ovariectomy; pyridinoline;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this study was to examine the effects of ENA Actimineral Resource A (ENA-A), seaweed origin alkaline water, on postmenopausal osteoporosis in ovariectomized (OVX) rats. The 12-week old Wistar rats were divided randomly into 4 groups: ovariectomized (OVX), OVX plus 0.5% ENA-A, OVX plus 5% ENA-A and OVX plus 10% ENA-A. A histopathological analysis indicated that ENA-A could prevent OVX-induced bone loss by increasing femur trabecular bone area in a dose-dependent manner. ENA-A significantly (p < 0.05) increased serum estradiol levels, decreased serum osteocalcin activity and suppressed serum pyridinoline (PYD) levels. The in vitro effects of ENA-A were also studied using MC3T3-E1 cells. ENA-A significantly stimulated cell proliferation and increased both ALP activity and calcium deposition in a dose-dependent manner. These results suggest that the treatment of ovariectomized rats with ENA-A not only prevents bone resorption but also appears to maintain the cancellous bone structure of postmeopausal osteoporosis.
引用
收藏
页码:35 / 43
页数:8
相关论文
共 136 条
[1]  
Riggs BL(1986)Involutional osteoporosis N Engl J Med 314 1676-1686
[2]  
Melton III IJ(1993)Pathogenesis of osteoporosis Lancet 341 797-805
[3]  
Dempster DW(1996)The biochemistry of bone. Metabolic bone disease, part Ι Endocrinol Metab Clin N Am 18 859-902
[4]  
Lindsay R(1981)Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone J Bio Chem 256 12760-12766
[5]  
Robey PG(1999)Osteoporosis in men J Clin Endocrinol Metab 84 3431-3434
[6]  
Price PA(1978)Menopausal changes in bone remodeling J Lab Clin Med 92 964-970
[7]  
Williamson MK(1994)Skeletal effects of estrogen Endocr Rev 15 275-300
[8]  
Lorthringer JW(2003)Management of osteoporosis due to ovarian failure Med Pediatr Oncol 41 222-227
[9]  
Bilezikian JP(1998)Biochemical markers of bone turnover. Applications for osteoporosis Endocrinol Metab Clin North Am 27 303-323
[10]  
Heaney RP(1996)New developments in biochemical markers for osteoporosis Calcif Tissue Int 59 S2-S9